| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 709928 | Null | 0.0178844438004191 | -0.24695744 |
| NSC 740275 | 5,6-Dihydro-6-(3-morpholinyl-1-propyl)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0178844438004191 | -0.090524656 |
| NSC 137679 | 9H-Purine-6(1H)-one, 2-amino-9-.beta.-D-ribofuranosyl-6-seleno- | 0.0178844438004194 | 0.064224201 |
| NSC 354258 | Null | 0.0178844438004194 | 0.36908116 |
| NSC 616511 | Null | 0.0178844438004194 | -0.37208893 |
| NSC 625498 | 4-Morpholinecarbodithioic acid, antimony complex | 0.0178844438004194 | 0.59245983 |
| NSC 627759 | 2'-Phenyl-17a-aza-D-homo-5-androsteno[17,16-c]pyrazol-3.beta.-yl acetate | 0.0178844438004194 | 0.16743686 |
| NSC 682866 | Ethanone, 1-[7-(4-chlorophenyl)-5,6-dihydro-9-methyl- 7H-benzo[h]thiazolo[2,3-b]quinazolin-10-yl]- | 0.0178844438004194 | 0.57425752 |
| NSC 701378 | 3-Pyridinecarbonitrile, 4-(4-chlorophenyl)- 6-[4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl]- 1,2-dihydro-2-oxo- | 0.0178844438004195 | 0.0077636596 |
| NSC 748264 | Null | 0.0179905510964914 | -0.076354805 |